Ceftazidime/Tazobactam Sodium

头孢他啶/他唑巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCeftazidime/Tazobactam Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2010/03/15
Country/TerritoryMainland China
CombinationsYes CeftazidimeTazobactam Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWelman (Xiang Bei) Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Zhonghemei Technology Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A